2.0
17. März 2009
Ehemaliger Mitarbeiter
Parma
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Multinational company operating in an interesting field - real life impact. The sheer size of the company allows (if you are lucky) a good level of international exchanges.
Kontras
Some parts of the company are not really working together. Opportunities are not the same in all sites. Considering the multinational dimension of the company, this is a big downside: perceived inequalities, especially if fostered by a less-than-adequate local plant management, can result in excessive employees turnover and low motivation. The pharma industry is still quite "shielded" from competition: this is both a plus and a minus, since inefficiencies are allowed to survive.